###begin article-title 0
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
Localization of an exonic splicing enhancer responsible for mammalian natural trans-splicing
###end article-title 0
###begin p 1
###xml 95 121 95 121 <email xmlns:xlink="http://www.w3.org/1999/xlink">hegardt@farmacia.far.ub.es</email>
To whom correspondence should be addressed. Tel: +34 93 402 4523; Fax: +34 93 402 4520; Email: hegardt@farmacia.far.ub.es The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 1
###begin p 2
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 635 643 635 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 894 899 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 909 917 909 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1001 1006 1001 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1093 1098 1093 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1177 1180 1177 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1186 1191 1186 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1256 1261 1256 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1285 1288 1285 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1298 1305 1298 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1389 1394 1389 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 76 79 <span type="species:ncbi:10116">rat</span>
###xml 215 218 <span type="species:ncbi:10116">rat</span>
###xml 448 453 <span type="species:ncbi:9606">human</span>
###xml 455 458 <span type="species:ncbi:9823">pig</span>
###xml 460 463 <span type="species:ncbi:9913">cow</span>
###xml 468 473 <span type="species:ncbi:10090">mouse</span>
###xml 505 508 <span type="species:ncbi:10116">Rat</span>
###xml 572 575 <span type="species:ncbi:10116">rat</span>
###xml 784 787 <span type="species:ncbi:10116">rat</span>
###xml 963 968 <span type="species:ncbi:9606">human</span>
###xml 1064 1067 <span type="species:ncbi:10116">rat</span>
###xml 1072 1077 <span type="species:ncbi:9606">human</span>
###xml 1150 1153 <span type="species:ncbi:10116">rat</span>
###xml 1407 1410 <span type="species:ncbi:10116">rat</span>
Carnitine octanoyltransferase (COT) produces three different transcripts in rat through cis- and trans-splicing reactions, which may lead to the synthesis of two proteins. Generation of the three COT transcripts in rat does not depend on sex, development, fat feeding, the inclusion of the peroxisome proliferator diethylhexyl phthalate in the diet or hyperinsulinemia. In addition, trans-splicing was not detected in COT of other mammals, such as human, pig, cow and mouse, or in Cos7 cells from monkey. Rat COT exon 2 contains two purine-rich sequences. Mutation of the rat COT exon 2 upstream box does not affect the trans-splicing in vitro between two truncated constructs containing exon 2 and its adjacent intron boundaries. In contrast, mutation of the downstream box from the rat sequence (GAAGAAG) to a random sequence or the sequence observed in the other mammals (AAAAAAA) decreased trans-splicing in vitro. In contrast, mutation of the AAAAAAA box of human COT exon 2 to GAAGAAG increases trans-splicing. Heterologous reactions between COT exon 2 from rat and human do not produce trans-splicing. HeLa cells transfected with minigenes of rat COT sequences produced cis- and trans-spliced bands. Mutation of the GAAGAAG box to AAAAAAA abolished trans-splicing and decreased cis-splicing in vivo. We conclude that GAAGAAG is an exonic splicing enhancer that could induce natural trans-splicing in rat COT.
###end p 2
###begin p 3
DDBJ/EMBL/GenBank accession nos AF144397-AF144399
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 422 425 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cis</italic>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c1">1</xref>
The precise removal of introns from pre-mRNA by splicing is an important step in the expression of genes. It requires the interaction of several proteins and small ribonucleoprotein particles, which all function in concert. These components recognize exon-intron boundaries at both 5' and 3' splice sites and then produce the necessary reactions to ligate the exons involved. Two kinds of splicing are observed in nature. Cis-splicing, by which introns from the same pre-mRNA are removed, and trans-splicing, in which two pre-mRNAs are processed to produce a mature transcript that contains exons from both precursors. The trans-splicing process has been described mostly in trypanosome, nematodes, plant/algal chloroplasts and plant mitochondria (1).
###end p 5
###begin p 6
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c2">2</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c3">3</xref>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 393 401 393 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c4">4</xref>
 A family of serine-arginine-rich RNA binding proteins, known as SR proteins, plays a critical role in the formation of active spliceosomes. The SR proteins recognize exonic splicing enhancers (ESEs) promoting both constitutive and regulated splicing by bringing the flanking splice sites. Trans-splicing efficiency may correlate with the presence of these ESE sequences (2,3). Trans-splicing in vitro only occurs when the 3' exon contains ESE sequences (4).
###end p 6
###begin p 7
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 410 413 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c6">6</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c12">12</xref>
###xml 71 74 <span type="species:ncbi:10116">rat</span>
 In the course of our research, natural trans-splicing was observed in rat carnitine octanoyltransferase (COT) pre-mRNAs (5). This mechanism produces three different transcripts: one produced by cis-splicing and two produced by trans-splicing, in which exons 2 and 3 are repeated. Western blot analysis of peroxisomal proteins revealed two translated proteins with molecular masses which may correspond to the cis-spliced as well as the trans-spliced RNAs in which exons 2 and 3 are repeated. Recently, trans-splicing corresponding to other genes has been observed in mammals. In some cases, mature mRNAs containing a mixture of exons from different genes have been observed; this transcript heterogeneity may contribute to phenotypic variation in mammals (6-12).
###end p 7
###begin p 8
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 513 521 513 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 764 772 764 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 794 799 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 823 830 823 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 903 908 903 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1045 1050 1045 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 45 48 <span type="species:ncbi:10116">rat</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
###xml 86 89 <span type="species:ncbi:9823">pig</span>
###xml 91 94 <span type="species:ncbi:9913">cow</span>
###xml 214 217 <span type="species:ncbi:10116">rat</span>
###xml 319 322 <span type="species:ncbi:10116">rat</span>
###xml 536 539 <span type="species:ncbi:10116">rat</span>
###xml 712 717 <span type="species:ncbi:9606">human</span>
###xml 1030 1033 <span type="species:ncbi:10116">rat</span>
 In this report we show that, in contrast to rat, other mammals such as human, mouse, pig, cow and Cos7 cells of monkey do not produce detectable trans-splicing of the COT gene. We also show that trans-splicing in rat COT is not due to any metabolic, nutritional, hormonal or developmental condition. Trans-splicing in rat is attributable in part to the occurrence of an ESE sequence (GAAGAAG). Trans-splicing is not found in other mammals, which have a conserved sequence, AAAAAAA, instead. Splicing experiments in vitro, in which the rat putative ESE sequence (GAAGAAG) was mutated either to a random sequence or to AAAAAAA, revealed a marked decrease in trans-splicing of the COT pre-mRNA. Moreover, when the human COT exon 2 box AAAAAAA was mutated to GAAGAAG in vitro a marked increase in trans-splicing was observed. In vivo experiments also showed that mutation of the GAAGAAG strongly decreased trans-splicing. This shows that the evolution from AAAAAAA to GAAGAAG, which does not affect the protein sequence, enabled the rat to produce trans-splicing of the COT pre-mRNA.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat treatment
###end title 10
###begin p 11
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c13">13</xref>
###xml 16 20 <span type="species:ncbi:10116">rats</span>
Groups of adult rats, weighing 200-250 g (three for each treatment) were fed for 7 days with a fat diet or a diet supplemented with diethylhexylphthalate (DEHP) as described (13), or injected i.p. with insulin (40 U/kg body weight) and killed at 30 min.
###end p 11
###begin title 12
Northern blot analysis and RNase H digestion of total RNA
###end title 12
###begin p 13
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c14">14</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 300 302 300 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c15">15</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 374 377 <span type="species:ncbi:10116">rat</span>
Total RNA from different samples used was extracted with guanidine isothiocyanate and purified by centrifugation through a CsCl cushion (14). Twenty micrograms of total liver RNA was incubated with the primer E4.r-2 (5'-CTTCTTAGCAGCTGCCAGTAG-3') and digested with 0.8 U RNase H as described (5). The 32P-labeled cDNA probe used corresponds to positions 31 to 1700 bp in the rat COT cDNA sequence (15). mRNA analysis by northern blot was performed as described (5).
###end p 13
###begin title 14
RT and PCR
###end title 14
###begin p 15
###xml 293 294 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 94 97 <span type="species:ncbi:9913">cow</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 106 109 <span type="species:ncbi:9823">pig</span>
###xml 184 188 <span type="species:ncbi:10116">rats</span>
RT was performed in 20 microl of a mixture containing 1 microg of total liver RNA from human, cow, mouse, pig or Cos7 cultured monkey cells or 1 microg of liver and intestine RNA from rats. Random hexamers were used as primers to synthesize the cDNAs. The reaction was performed as described (5). The conditions for the PCR were 94degreesC for 45 s; 55degreesC for 45 s and 72degreesC for 45 s for 35 cycles. The bands were purified with Quiaex kit (Stratagene) and sequenced with an automatic sequencer ABI prism.
###end p 15
###begin title 16
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Constructs, pre-mRNA synthesis and trans-splicing reaction in vitro
###end title 16
###begin p 17
###xml 47 48 47 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ecl</italic>
###xml 371 374 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 441 444 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu</italic>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c16">16</xref>
###xml 671 677 671 677 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GTCTAC</underline>
###xml 962 969 962 969 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CAGATGC</underline>
###xml 1017 1018 1017 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1033 1036 1033 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1174 1177 1174 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1183 1186 1183 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1254 1255 1254 1255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1281 1284 1281 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 1448 1455 1448 1455 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TTTTTTT</underline>
###xml 1848 1850 1848 1850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c17">17</xref>
###xml 2070 2073 2066 2069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu</italic>
###xml 2527 2534 2499 2506 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GTTGTTG</underline>
###xml 2840 2841 2812 2813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2868 2871 2840 2843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ecl</italic>
###xml 1765 1770 <span type="species:ncbi:9606">human</span>
###xml 1814 1819 <span type="species:ncbi:9606">human</span>
###xml 1941 1946 <span type="species:ncbi:9606">human</span>
Constructs A and B were prepared as described (5). Construct A1 was also prepared as described (5) but with less polylinker region from Bluescript vector. To this end, a fragment was amplified with E2.f (5'-TTTTCTTACTGTGACTATACCATGG-3') and I2.r (5'-CTACACTAGAAGATTATGAACATAC-3') and subcloned in a plasmid Bluescript SK+ previously cut with Ecl136II, an isoschizomer of SacI that produces blunt ends. All amplifications were performed with Pfu polymerase. Construct C was prepared by PCR using megaprimer for asymmetric PCR as described (16) taking construct B as template. The first PCR amplification was carried out with primers T7 and MutESE1.f (5'-CAATTGGCTAAGTCAATTGTCTACCGAACATTCCAGTACCAGG-3'). The second PCR was performed with primer T3 and with the purified product of the first amplification (megaprimer). Construct D was also prepared by PCR taking construct B as template and primers I1.f (5'-CATGGGGTGCTAAATCCACA-3') and MutESE2.r (5'-CTGACTCAAGGTACAGATGCAGTGATTCTTC-3') and subcloned into Bluescript SK+ digested with EcoRV. The sequences underlined above indicate the mutated nucleotides. To reduce their polylinker regions, constructs C and D were cut with XhoI and EcoRI, blunt ended with the Klenow fragment and cloned in Bluescript SK+ previously digested with SacI and blunt ended with T4 DNA polymerase. Construct E was prepared by PCR taking construct B as template. The primers used were I1.f and MutESE3.r (5'-CTGACTCAAGGTATTTTTTTAGTGATTCTTC-3'). Construct F was prepared by the megaprimer technique taking construct A as template. Primers for the first amplification were E2.f and MutESE3.r. In the second amplification primer I2.r was used. The constructs G, H, I and J were obtained by PCR amplifications using genomic DNA obtained from human liver. The primers were designed using the human COT cDNA sequence AF168793 (17) and the genomic sequence ACC005045 from the DDBJ/EMBL/GenBank database that contains the human COT genomic sequence. PCR was performed in a total volume of 50 microl with 300 ng of genomic DNA, 1 mM of each primer and Pfu polymerase. The conditions for PCR were 94degreesC for 5 min followed by 30 cycles of 94degreesC for 45 s, 53degreesC for 45 s and 72degreesC for 1 min. Constructs G and H were obtained with primers hE2.f (5'-GTTTCCTATTGTGATTTTATC-3') and hI2.r (5'-TATATACTAAAACATTATTAAC-3'), and hE2.r (5'-CTGATTCAAGGTATTTTTTTAATG-3') and hI1.f (5'-GCTGGTACCAAGTCCTAGATATGC-3'), respectively. Construct I was obtained with primers hI1.f and MutESE4.r (5'-CTGATTCAAGGTTGTTGTTGAATGATTCTTCAAG-3'). Construct J was obtained using a megaprimer asymmetric PCR; in the first PCR primers hE2.f and mutESE4.r were employed to produce the megaprimer, the second PCR was performed using the megaprimer and primer hI2.r. All the blunt-ended PCR fragments (E-J) were subcloned in pBluescript SK+, previously digested with Ecl136II.
###end p 17
###begin p 18
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 192 200 192 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
 For the trans-splicing experiments, construct B was linearized with EcoRI, constructs C and D with HindIII and constructs A and E-J with NotI and all were transcribed with T3 RNA polymerase. In vitrotrans-splicing assays were carried out as described (5). The products of trans-splicing were loaded on a denaturing 6% polyacrylamide/7 M urea gel. Autoradiographs of the labeled bands in the gels were scanned with a Molecular Dynamics laser densitometer using the internal integration to determine peak areas with the ImageQuant program and also with the PhosphorImager technique. The percentage inhibition was calculated from the values of the integration areas of the bands.
###end p 18
###begin title 19
Preparation of COT minigene constructs, cell culture and transfections
###end title 19
###begin p 20
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f8">8</xref>
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu</italic>
###xml 195 196 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 772 775 767 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 45 48 <span type="species:ncbi:10116">rat</span>
A minigene containing several regions of the rat COT gene (construct E2E3COT, seen in Fig. 8) was created by Pfu polymerase (Clontech) PCR amplification of 1 ng from genomic DNA lambdaGA5 clone (5). To amplify different fragments of this minigene, several primers were used. Primers I1.f (5'-CATGGGGGTGCTAAATCCACA-3') and I2.r (5'-CTACACTAGAAGATTATGAAGATAC-3') amplify a fragment containing 125 nt of the 3' region of intron 1 (which contains the branch point), the whole of exon 2 and 25 nt of the 5' splice site of intron 2. Primers I2.f (5'-GCATTGCAGTTTTCACATTGCC-3') and COT291.r (5'-CCAGTTTCTTTTTCCTTTAGCCC-3') amplify a fragment containing 115 nt of the 3' splice site of intron 2 (containing the branch point) and the whole of exon 3. Products were cloned into the EcoRV site in plasmid pcDNA3 (Invitrogen) and sequenced. A mutated minigene of E2E3COT (E2E3COT-ESEmut) was obtained by using the site-directed mutagenesis kit from Stratagene. The primers used were COTE2G/A.f (5'-CCGTTCCTTCGCTTGAAGAATCACTAAAAAAATACCTTGAGTCAG-3') and COTE2G/A.r (5'-CTGACTCAAGGTATTTTTTTAGTGATTCTTCAAGCGAAGGAACGG-3'). The introduction of mutations of the E2E3COT-ESEmut minigene was confirmed by sequencing.
###end p 20
###begin p 21
###xml 223 224 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 644 646 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c14">14</xref>
###xml 647 649 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c18">18</xref>
###xml 1000 1001 985 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 1008 1011 993 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1017 1022 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 98 104 <span type="species:ncbi:9913">bovine</span>
###xml 1039 1042 <span type="species:ncbi:10116">rat</span>
 HeLa cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal bovine serum, 100 i.u./ml penicillin and 100 microg/ml streptomycin. The cells were cultured in 65 mm plates. Cells (1.6 x 106) were transiently transfected with 5 microg of either E2E3COT plasmid or E2E3COT-ESEmut plasmid. Plasmid dosage was kept constant by the addition of an appropriate amount of DNA salmon sperm. Plasmid pCMVbGAL (cytomegalovirus promoter beta-galactosidase; 3 microg) was included as an internal control in co-transfections. Transfection experiments were performed by the calcium phosphate method as previously described (14,18). After incubation for a further 24 h the cells were collected and RNA was extracted by trizol reagent (Bethesda Research Laboratories). Each series of experiments was performed at least four times and each transfection was performed in triplicate. RNA samples were treated with DNase I to eliminate the plasmidic DNA from transfection as described (5). The cis- and trans-spliced mRNA of rat COT was analyzed by RT-PCR.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 40 43 <span type="species:ncbi:10116">rat</span>
Of the various mammals studied only the rat produced trans-splicing
###end title 23
###begin p 24
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 319 326 319 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 330 339 330 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> in vitro</italic>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 497 500 <span type="species:ncbi:10116">rat</span>
The occurrence of trans-splicing in exons 2 and 3 of the rat COT pre-mRNAs (5) produced two different transcripts, with the following compositions: exon1-exon2-exon2-exon3 etc. and exon1-exon2-exon3-exon2-exon3 etc., in addition to the cis-spliced transcript (exon1-exon2-exon3 etc.). This phenomenon was observed both in vivo and in vitro. We thus attempted to determine: (i) whether trans-splicing of the COT gene occurs in other mammals, and (ii) the molecular basis for this phenomenon in the rat.
###end p 24
###begin p 25
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f1">1</xref>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gke428tb1">1</xref>
###xml 652 655 652 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 661 666 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 76 79 <span type="species:ncbi:9823">pig</span>
###xml 81 84 <span type="species:ncbi:9913">cow</span>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 227 230 <span type="species:ncbi:10116">rat</span>
###xml 246 249 <span type="species:ncbi:9913">cow</span>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
###xml 449 452 <span type="species:ncbi:9823">pig</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 504 507 <span type="species:ncbi:9913">cow</span>
###xml 512 515 <span type="species:ncbi:10116">rat</span>
###xml 542 545 <span type="species:ncbi:10116">rat</span>
###xml 579 582 <span type="species:ncbi:9913">cow</span>
###xml 598 601 <span type="species:ncbi:10116">rat</span>
 We first amplified mRNAs by RT-PCR from several mammals, among them human, pig, cow, mouse and Cos cells from monkey (Fig. 1). A single band was observed in all cases. This band was obtained whether the primers used were from rat (not shown) or cow. The band of each species was excised from the gel and, after sequencing, it was found to correspond to the cis-spliced transcript. The sequences of exon 2 of the COT gene from mouse, Cos7 cells and pig are shown in Table 1 together with those of human, cow and rat. The amplification of the rat mRNAs, using primers from either cow (not shown) or rat, shows the three-band pattern that corresponds to cis- and trans-spliced transcripts, as expected.
###end p 25
###begin title 26
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 18 21 <span type="species:ncbi:10116">rat</span>
Trans-splicing in rat COT depends on the gene sequence and not on sex, development or metabolic condition
###end title 26
###begin p 27
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f1">1</xref>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f2">2</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c19">19</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f2">2</xref>
###xml 918 919 918 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 1356 1357 1356 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f3">3</xref>
###xml 1499 1500 1499 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f3">3</xref>
###xml 1561 1564 1561 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1570 1575 1570 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1651 1656 1651 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 43 46 <span type="species:ncbi:10116">rat</span>
###xml 133 136 <span type="species:ncbi:10116">rat</span>
###xml 300 303 <span type="species:ncbi:10116">rat</span>
###xml 537 541 <span type="species:ncbi:10116">rats</span>
###xml 610 614 <span type="species:ncbi:10116">rats</span>
###xml 984 988 <span type="species:ncbi:10116">rats</span>
###xml 1101 1105 <span type="species:ncbi:10116">rats</span>
###xml 1669 1672 <span type="species:ncbi:10116">rat</span>
Once it had been established that only the rat produced trans-splicing (Fig. 1), we examined whether the trans-splicing observed for rat COT could be either tissue-dependent or produced as a result of metabolic alteration, or dependent on sex or development. RT-PCR amplification of transcripts from rat liver and intestine gave the three-transcript pattern (Fig. 2), which was also observed in other tissues such as testis, kidney, heart and brown adipose tissue (data not shown). We then performed RT amplifications of total RNAs from rats at different developmental stages: fetuses of 20 days, and suckling rats of 1, 9 and 21 days of age. The COT mRNA levels during the suckling period are transcriptionally regulated (19). These developmental studies in liver and intestine also showed the three-band pattern (Fig. 2). The variability in the relative proportion of the three transcripts had been observed before (5), but no explanation has been found. Both male and female adult rats (six animals in each case) also gave three mature transcripts of the COT gene (data not shown). Groups of three rats were treated with insulin or fed with a fat diet, or with a diet supplemented with DEHP, a peroxisomal proliferator, as described in Materials and Methods. These treatments produced small changes in the COT mRNA levels with respect to controls (Fig. 3A) except DEHP treatment, which produced a 12-fold increase. Total RNAs were incubated with a specific primer and digested with RNase H (Fig. 3B). Once more, the three mature transcripts corresponding to cis- and trans-splicing were also observed. All these results taken together suggest that trans-splicing in rat COT depends on the gene sequence rather than on any metabolic, nutritional, hormonal or developmental condition.
###end p 27
###begin title 28
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Identification of possible ESEs in exon 2 which may promote trans-splicing in experiments in vitro
###end title 28
###begin p 29
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c2">2</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c3">3</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gke428tb1">1</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c20">20</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c22">22</xref>
###xml 347 350 <span type="species:ncbi:10116">rat</span>
The occurrence of an ESE sequence in the acceptor exon is necessary for artificial trans-splicing to occur (2,3). Splicing enhancers facilitate the assembly of protein complexes on pre-mRNAs containing a 3' splice site, and these complexes are sufficiently stable to interact with 5' splice sites located in other RNA molecules. By examination of rat COT exon 2, at least two purine-rich sequences were identified at positions 79 (GAAGAACGAA, named upstream box) and 147 (GAAGAAG, named downstream box) (Table 1), which are similar to ESE sequences previously described (20-22).
###end p 29
###begin p 30
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f4">4</xref>
###xml 442 445 <span type="species:ncbi:10116">rat</span>
 To assess the individual roles of the downstream and upstream boxes in trans-splicing, different truncated pre-mRNAs were prepared: a wild-type donor pre-mRNA containing only exon 2 and the 5' splice site of intron 2 (construct A), and a wild-type acceptor pre-mRNA, containing the branch-point region, the 3' splice site of intron 1 and exon 2 (construct B) (Fig. 4). We then separately mutated the upstream and the downstream boxes of the rat exon 2 in construct B. The sequence GAAGAA of the upstream box (construct B) was changed to GTCTAC (construct C), and the sequence GAAGAAG of the downstream box was changed to GCATCTG (construct D).
###end p 30
###begin p 31
###xml 8 9 8 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f4">4</xref>
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 154 156 154 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 187 195 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 394 402 394 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
 Figure 4 shows trans-splicing assays with the combination of donor construct A with acceptor constructs B, C and D. The donor pre-mRNA (construct A) was 32P-labeled during transcription in vitro and the unlabeled acceptors were added to the trans-splicing reaction. The combination of donor A with acceptor C (random mutated upstream box) produced slight changes in the trans-splicing product in vitro when compared with the AxB product (lanes 7-9 and lanes 3-5). However, the trans-splicing between donor A and acceptor D (random mutated downstream box) was reduced by 60% (compare lanes 11-13 with lanes 3-5). Mutation of both upstream and downstream boxes did not modify trans-splicing when compared with results of the downstream ESE box (data not shown). These results show that the downstream box behaves as an ESE sequence, while the upstream box does not seem to contribute to the process.
###end p 31
###begin title 32
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 116 124 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 23 26 <span type="species:ncbi:10116">rat</span>
Mutation of downstream rat ESE sequence to the sequence observed in other mammals strongly decreases trans-splicing in vitro
###end title 32
###begin p 33
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gke428tb1">1</xref>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 728 736 728 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 736 741 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 896 901 896 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1142 1147 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1157 1164 1157 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vivo</italic>
###xml 41 44 <span type="species:ncbi:10116">rat</span>
###xml 272 275 <span type="species:ncbi:10116">rat</span>
###xml 344 347 <span type="species:ncbi:10116">rat</span>
###xml 528 531 <span type="species:ncbi:10116">rat</span>
###xml 786 789 <span type="species:ncbi:10116">rat</span>
###xml 966 971 <span type="species:ncbi:9606">human</span>
###xml 1089 1092 <span type="species:ncbi:10116">rat</span>
We first compared the composition of the rat COT exon 2 sequence with the corresponding sequences from those mammals in which trans-splicing did not occur (Table 1). The upstream box in these mammals differed only slightly (0, 1 or 2 nucleotides changed) from that in the rat. In contrast, the downstream box was invariably AAAAAAA, whereas in rat it was GAAGAAG. Taken together, these results emphasize the relevance of the downstream ESE box in trans-splicing. We attempted to assess whether the change of GAAGAAG (present in rat exon 2) to AAAAAAA (seen in all the other mammals studied) is responsible for the absence of trans-splicing in these species. To this end, three types of experiments were performed. In the first, in vitrotrans-splicing was carried out with constructs of rat exon 2 in which the downstream box GAAGAAG was mutated to AAAAAAA, to see whether this mutation decreased trans-splicing. In the second sets of experiments, the AAAAAAA box of human exon 2 was mutated to GAAGAAG, to see whether there was a gain of function. The third set of experiments showed that rat COT minigenes transfected in HeLa cells produced trans-splicing in vivo, and that mutation of the GAAGAAG box abolished the phenomenon.
###end p 33
###begin p 34
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f5">5</xref>
###xml 288 296 288 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vitro</italic>
###xml 368 375 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 191 194 <span type="species:ncbi:10116">rat</span>
###xml 402 405 <span type="species:ncbi:10116">rat</span>
 To perform the first experiment two truncated pre-mRNAs were also prepared: construct E, in which the downstream box in rat construct B was mutated to AAAAAAA, and construct F, in which the rat donor construct A was also mutated in the downstream box to AAAAAAA. Figure 5 shows that the in vitro combination of donor F and acceptor E, which reflects what is produced in vivo in mammals other than the rat, inhibits trans-splicing (50%) as compared with the wild-type trans-splicing (donor A and acceptor B) (see lanes 8-10 and 3-5).
###end p 34
###begin title 35
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Mutation of human downstream box sequence to the sequence observed in rat strongly increased trans-splicing in vitro
###end title 35
###begin p 36
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f6">6</xref>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 816 821 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 995 1000 995 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1115 1120 1115 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1283 1291 1283 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vitro</italic>
###xml 1412 1417 1412 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 27 30 <span type="species:ncbi:10116">rat</span>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 390 395 <span type="species:ncbi:9606">human</span>
###xml 438 443 <span type="species:ncbi:9606">human</span>
###xml 485 488 <span type="species:ncbi:10116">rat</span>
###xml 593 598 <span type="species:ncbi:9606">human</span>
###xml 719 724 <span type="species:ncbi:9606">human</span>
###xml 760 765 <span type="species:ncbi:9606">human</span>
###xml 932 935 <span type="species:ncbi:10116">rat</span>
###xml 959 964 <span type="species:ncbi:9606">human</span>
###xml 1070 1073 <span type="species:ncbi:10116">rat</span>
###xml 1095 1098 <span type="species:ncbi:10116">rat</span>
###xml 1356 1359 <span type="species:ncbi:10116">rat</span>
To analyze the role of the rat COT downstream ESE sequence, four new truncated pre-mRNAs were prepared: a donor human pre-mRNA containing only human exon 2 and the 5' splice site of intron 2 (construct G), and an acceptor human pre-mRNA, containing the branch point region, the 3' splice site of intron 1 and exon 2 (construct H) (Fig. 6). We then mutated the downstream AAAAAAA box of the human exon 2 in constructs G and H so that this human sequence was changed to GAAGAAG (seen in rat) (constructs J and I, respectively). The combination of constructs G and H corresponding to the natural human exon 2 only produced trans-splicing when a high amount of acceptor was present (lanes 8-11). The combination of mutated human exon 2 as a donor with non-mutated human acceptor exon 2 (JxH) only slightly increased the trans-splicing reaction (16%) (see lanes 19-22). The combination of donor construct G with acceptor I, in which the rat ESE box was present in human exon 2 (lanes 3-6), increased trans-splicing (60%) compared with combination of constructs GxH as in the rat, suggesting that the rat ESE box induces trans-splicing when present in the acceptor exon 2. Similar trans-splicing was produced when constructs JxI (both containing the mutated GAAGAAG) (lanes 14-17) reacted in vitro (60%). This gain of function is attributable exclusively to the rat COT exon 2 downstream ESE, which appears to promote trans-splicing.
###end p 36
###begin title 37
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 17 20 <span type="species:ncbi:10116">rat</span>
Relevance of the rat downstream ESE in heterologous trans-splicing in vitro
###end title 37
###begin p 38
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f7">7</xref>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 29 32 <span type="species:ncbi:10116">rat</span>
###xml 99 102 <span type="species:ncbi:10116">rat</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 360 363 <span type="species:ncbi:10116">rat</span>
###xml 491 494 <span type="species:ncbi:10116">rat</span>
###xml 581 586 <span type="species:ncbi:9606">human</span>
###xml 647 652 <span type="species:ncbi:9606">human</span>
###xml 716 719 <span type="species:ncbi:10116">rat</span>
To test the relevance of the rat COT exon 2 ESE sequence in heterologous trans-splicing, wild-type rat donor COT exon 2 (construct A1) was reacted with human acceptor COT exon 2 (construct H) in the same conditions. No trans-splicing product was observed (Fig. 7, lanes 1-3). When the human acceptor COT exon 2 was mutated in the downstream box AAAAAAA to the rat ESE GAAGAAG (construct I), trans-splicing occurred (compare lanes 4-6 with 1-3). This experiment showed that, on the one hand, rat COT exon 2 as a donor does not by itself produce trans-splicing when it reacts with a human acceptor (lacking the ESE box). On the other hand, when the human construct is mutated in the corresponding box AAAAAAA with the rat ESE sequence (GAAGAAG) trans-splicing is produced.
###end p 38
###begin title 39
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 132 139 132 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 12 15 <span type="species:ncbi:10116">rat</span>
Mutation of rat COT exon 2 ESE sequence to the sequence observed in COT exon 2 from other mammals strongly decreases trans-splicing in vivo
###end title 39
###begin p 40
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f8">8</xref>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f8">8</xref>
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 555 560 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f8">8</xref>
###xml 24 27 <span type="species:ncbi:10116">rat</span>
###xml 116 119 <span type="species:ncbi:10116">rat</span>
###xml 188 191 <span type="species:ncbi:10116">rat</span>
To test the role of the rat COT exon 2 ESE sequence in trans-splicing in vivo, HeLa cells were transfected with two rat COT minigenes (Fig. 8A). The first of these minigenes contained the rat COT exon 2 ESE sequence (GAAGAAG) intact and the second was identical to the first but the ESE sequence had been mutated to AAAAAAA. After 24 h, total RNA was isolated from transfected cells and RT-PCR amplification was performed with specific primers to detect either the formation of trans-spliced mRNA (Fig. 8B, left) or the simultaneous formation of cis- and trans-spliced mRNAs (Fig. 8B, right).
###end p 40
###begin p 41
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f8">8</xref>
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f8">8</xref>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 335 338 335 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 422 425 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 493 496 493 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 592 595 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 649 652 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke428f8">8</xref>
###xml 848 856 848 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 877 884 877 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 936 941 936 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 956 964 956 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 969 976 969 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1049 1054 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 549 552 <span type="species:ncbi:10116">rat</span>
 Transfected HeLa cells produced a trans-spliced band (Fig. 8B, wt, left) composed of exon2-exon2-exon3, which was not produced when the ESE sequence GAAGAAG was mutated to AAAAAAA (Fig. 8B, Mut, left). The RT-PCR amplified bands using a different set of primers that involve exon 2 and exon 3 show that in addition to trans-splicing, cis-spliced bands exon2-exon3 were also produced. In the conditions of the experiment, cis-spliced bands were stronger than trans-spliced bands, showing that cis-splicing is preferred over trans-splicing. When the rat COT ESE sequence was mutated, both the cis- and the trans-splicing were affected, but while the cis-splicing was slightly decreased, trans-splicing disappeared (Fig. 8B, right). Any of the sets of primers used could amplify endogenous HeLa COT. These experiments show that the splicing produced in vitro was also reproduced in vivo, and that the ESE sequence GAAGAAG plays a role in trans-splicing both in vitro and in vivo, since its mutation to the sequence observed in other mammals decreases trans-splicing.
###end p 41
###begin title 42
DISCUSSION
###end title 42
###begin p 43
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 48 51 <span type="species:ncbi:10116">rat</span>
The occurrence of natural trans-splicing in the rat COT pre-mRNAs, producing two different transcripts involving repetition of exons 2 and 3, had been reported previously by our group (5). The question was then to determine the molecular basis of this phenomenon. One possibility was that metabolic, sexual or developmental factors might be responsible for trans-splicing. However, the present study clearly shows that all conditions tested determine the generation of natural trans-splicing. These results emphasize that the characteristics of the gene are responsible for such phenomena.
###end p 43
###begin p 44
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c23">23</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c5">5</xref>
###xml 622 627 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 48 51 <span type="species:ncbi:10116">rat</span>
###xml 186 189 <span type="species:ncbi:10116">rat</span>
 The occurrence of in vivotrans-splicing in the rat COT gene and its absence in other mammals is surprising. The simplest explanation was that some structural feature was present in the rat COT gene and not present in other mammals. In one type of trans-splicing an intron of one pre-mRNA interacts with an intron of a second pre-mRNA, enhancing the recombination of splice sites between two pre-mRNAs (23). This is not the case in the COT pre-mRNA constructs (5), which do not require intronic RNA-RNA interactions among substrates. Another explanation is that the COT gene requires specialized elements such as ESEs for trans-splicing to occur.
###end p 44
###begin p 45
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 254 263 254 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> in vitro</italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 34 37 <span type="species:ncbi:10116">rat</span>
###xml 536 539 <span type="species:ncbi:10116">rat</span>
 The examination of exon 2 of the rat COT gene revealed two purine-rich sequences, which may facilitate the trans-splicing reaction as ESEs. Accordingly, we independently mutated these two putative ESE sequences and observed the effects on trans-splicing in vitro. The upstream sequence, which was nearly identical in the COT exon 2 of all mammals sequenced, did not produce any quantitative change in trans-splicing after mutation, from which we concluded that, by itself, it was not responsible for the trans-splicing observed in the rat.
###end p 45
###begin p 46
###xml 178 180 178 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">. </italic>
###xml 192 200 192 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 47 50 <span type="species:ncbi:10116">rat</span>
###xml 388 391 <span type="species:ncbi:10116">rat</span>
###xml 553 556 <span type="species:ncbi:10116">rat</span>
 Different behavior was observed in downstream rat exon 2 ESE sequence GAAGAAG, which was different from that seen in the rest of the mammals studied, which is invariably AAAAAAA. Experiments in vitro with the randomly mutated downstream ESE produced a marked decrease in trans-splicing (residual capacity 40%) with respect to control. These results were confirmed by the mutation of the rat downstream ESE sequence to AAAAAAA. Once more, this mutation decreased trans-splicing by 50%. From this study it is clear that sequence GAAGAAG in exon 2 of the rat COT gene strongly increases trans-splicing.
###end p 46
###begin p 47
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 417 425 417 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 555 560 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 159 162 <span type="species:ncbi:10116">rat</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
###xml 457 460 <span type="species:ncbi:10116">rat</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
###xml 596 599 <span type="species:ncbi:10116">rat</span>
 The experiments of trans-splicing with human COT exon 2 illustrate the relevance of the ESE GAAGAAG sequence in trans-splicing. The inclusion of the putative rat downstream ESE sequence, instead of that naturally found in human, restored the ability of human exon 2 to produce trans-splicing, since there was a marked increase in trans-splicing compared to control. This was confirmed in heterologous trans-splicing in vitro, in which the inclusion of the rat ESE sequence GAAGAAG instead of the human AAAAAAA sequence induced to human exon 2 to produce trans-splicing when interacting with the rat exon 2.
###end p 47
###begin p 48
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 240 243 240 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 406 409 406 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 472 477 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 493 500 493 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 556 559 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 603 608 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 685 688 685 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 80 83 <span type="species:ncbi:10116">Rat</span>
 To confirm these results in vitro, a set of experiments was performed in vivo. Rat COT minigenes containing regions of intron 1, exon 2, intron 2 and exon 3 produced trans-splicing in transfected HeLa cells. These constructs also produced cis-spliced products in a much higher amount than trans-spliced products. This could be shown because under competitive conditions PCR amplifications showed stronger cis-spliced bands. Importantly, mutation in the ESE box abolished trans-splicing bands in vivo. Moreover, the mutation of the ESE band also decreased cis-splicing, although to a lesser extent than trans-splicing. This result is not surprising since the influence of ESE boxes on cis-splicing is well documented.
###end p 48
###begin p 49
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c2">2</xref>
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c3">3</xref>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c20">20</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c22">22</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c24">24</xref>
###xml 380 383 380 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 480 481 480 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 497 500 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c25">25</xref>
###xml 688 691 685 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 729 731 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke428c21">21</xref>
###xml 993 998 990 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1302 1307 1299 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1525 1530 1522 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 633 638 <span type="species:ncbi:9606">human</span>
###xml 956 959 <span type="species:ncbi:10116">rat</span>
###xml 1255 1258 <span type="species:ncbi:10116">rat</span>
 Previous experiments with artificial genes had shown that ESE enhancers activate trans-splicing (2,3). Moreover, ESE enhancers are also necessary for many cis-splicing reactions (20-22), which they trigger by binding to SR proteins, a family of modular splicing factors bearing one or more RNA recognition motifs and an arginine/serine (RS)-rich region (24). Curiously, previous cis-splicing experiments showed that if an SR-dependent enhancer is changed either to (AAAAAAGGGGGG)2 or poly(A) the cis-splicing reaction is inhibited (25). Recently, it was also shown that when another enhancer, activated by SR proteins, from the the human beta-globin pre-mRNA, is changed to AAAAAAA, the cis-splicing reaction is also inhibited (21). These observations indicate that the function of SR proteins is compromised if the enhancer sequence is changed to AAAAAAA. From an evolutionary point of view, we can postulate that there was a mutation in the COT gene in rat as a result of which it produced trans-splicing and thus generated two peroxisomal proteins. It is important to stress that no change is produced in the encoded protein when GAAGAAG is mutated to AAAAAAA (in both cases the predicted sequence is Leu-Lys-Lys). Thus, overlapping protein coding in rat and RNA recognition elements to facilitate trans-splicing may be co-selected during evolution to acquire the encoding of a new protein with unknown catalytic properties or cellular localization. This is the first report of the occurrence of an ESE box that enhances trans-splicing in mammals.
###end p 49
###begin title 50
Figures and Tables
###end title 50
###begin p 51
###xml 505 508 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 569 574 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 646 649 646 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 89 92 <span type="species:ncbi:9913">cow</span>
###xml 94 100 <span type="species:ncbi:9913">bovine</span>
###xml 103 106 <span type="species:ncbi:9823">pig</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 115 118 <span type="species:ncbi:10116">rat</span>
###xml 198 204 <span type="species:ncbi:9913">bovine</span>
###xml 329 332 <span type="species:ncbi:10116">rat</span>
###xml 374 377 <span type="species:ncbi:10116">rat</span>
###xml 529 532 <span type="species:ncbi:10116">rat</span>
###xml 609 612 <span type="species:ncbi:10116">rat</span>
###xml 670 673 <span type="species:ncbi:10116">rat</span>
 RT-PCR amplification of COT mRNAs in various mammals. RT of total liver RNA from mouse, cow (bovine), pig, human, rat and Cos7 (monkey) cultured cells was performed. The primers used were from the bovine COT cDNA: bE2.f (5'-TGCATGGTACCATAAAATGGAAAATCAACTGGC-3') and bE5.r (5'-CGGAATTGATTCATATCTAGAGGAGTATTTCC-3') except for the rat cDNA which was amplified with homologous rat primers E2.f (5'-TTTTCTTACTGTGACTATACCATGG-3') and E5.r (5'-GGTTCATGTCTAGAGGAG-3'). The bands were sequenced and correspond to cis-splicing at 493 (in rat) and 478 bp (in other mammals), and trans-splicing (629 and 754 bp) only in rat. The small difference in size of cis-spliced bands among rat and other mammals is due to the differences in the primers used.
###end p 51
###begin p 52
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 42 45 <span type="species:ncbi:10116">rat</span>
###xml 136 139 <span type="species:ncbi:10116">rat</span>
###xml 180 184 <span type="species:ncbi:10116">rats</span>
 Developmental trans-splicing analysis in rat liver and intestine by RT-PCR. Total RNA was extracted from liver and intestine of 20-day rat fetus (lane -20), 1-, 9- and 21-day-old rats. RT-PCR was performed. The primers used in the amplification were E1.f (5'-GAGTGCAGAGAGCCAAGCCGGG-3') and E7.r (5'-GGCCCAACAGGTTCATTCCAG-3'). The bands observed correspond to cis-splicing (755 bp) and trans-splicing (891 and 1016 bp).
###end p 52
###begin p 53
###xml 88 89 88 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 186 187 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 81 85 <span type="species:ncbi:10116">rats</span>
###xml 133 137 <span type="species:ncbi:10116">rats</span>
###xml 288 292 <span type="species:ncbi:10116">rats</span>
 Northern blot analysis and RNase H digestion of total RNA from liver of treated rats. (A) Northern blot of liver COT mRNA levels of rats treated as described in Materials and Methods. (B) Representative results of three experiments in which 20 microg of total RNA from livers of treated rats was incubated with the primer E4.r-2 and digested with RNase H (+). The lanes marked with - correspond to samples not digested with RNase H. The diagram shows the expected products formed after binding the primer E4.r-2 to RNA and digesting with RNase H as described (5).
###end p 53
###begin p 54
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 109 117 109 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 42 45 <span type="species:ncbi:10116">rat</span>
 Random mutation on the downstream box of rat exon 2 inhibits trans-splicing in vitro. Trans-splicing assays in vitro contained 0.9 ng (16 fmol) of radiolabeled wild-type donor (A) pre-mRNA (lanes 1-13) and increasing amounts, 1, 10 and 25 ng (11, 111 and 277 fmol), of either wild-type acceptor B (lanes 3-5), or mutated purine-rich boxes, acceptor C (lanes 7-9) and acceptor D (lanes 11-13). The letters XXXXXX in acceptor C indicate that the wild-type sequence GAAGAA of the upstream box was mutated to GTCTAC, and YYYYYY denote that the wild-type downstream box sequence GAAGAAG was mutated to GCATCTG. Product bands were mapped by RT-PCR. Splicing products and intermediates are depicted on the right. Lane M contains the molecular weight markers. Lane 1 corresponds to an incubation in the absence of any acceptor but in the presence of ATP. Lanes 2, 6 and 10 represent controls without ATP but with 50 ng of acceptor. Bands in lanes 7-9 and in 11-13 represent an average of 105 and 60% with respect to bands seen in lanes 3-5, respectively. The branch-points are shown by circles in the acceptor constructs.
###end p 54
###begin p 55
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 212 214 212 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 39 42 <span type="species:ncbi:10116">rat</span>
 Mutation on the downstream ESE box of rat exon 2 from GAAGAAG to AAAAAAA inhibits trans-splicing in vitro. Trans-splicing assays in vitro contained 0.9 ng (16 fmol) of 32P-radiolabeled A pre-mRNA (lanes 1-5) or 32P-radiolabeled F pre-mRNA (lanes 6-10) and increasing amounts, 25, 50 and 100 ng (280, 555 and 1108 fmol), of either acceptor B (lanes 3-5) or acceptor E (lanes 8-10). The letters AAAAAAA in the F donor and E acceptor indicate that the wild-type downstream ESE box GAAGAAG was mutated to AAAAAAA. The molecular weight markers are shown to the left. Lanes 1 and 6 correspond to incubations in the absence of any acceptor but in the presence of ATP. Lanes 2 and 7 represent controls without ATP but with 200 ng of constructs B and E, respectively. Bands in lanes 8-10 represent an average of 50% of bands seen in lanes 3-5.
###end p 55
###begin p 56
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 212 214 212 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
 Mutation on the downstream box of human exon 2 from AAAAAAA to GAAGAAG increased trans-splicing in vitro. Trans-splicing assays in vitro contained 0.9 ng (16 fmol) of 32P-radiolabeled G pre-mRNA (lanes 1-11) or 32P-radiolabeled J pre-mRNA (lanes 12-22) and increasing amounts, 25, 50, 100 and 200 ng (280, 555, 1108 and 2220 fmol), of either acceptor I (lanes 3-6 and 14-17) or acceptor H (lanes 8-11 and 19-22). The letters GAAGAAG in the I acceptor and J donor indicate that the human wild-type downstream box AAAAAAA was mutated to GAAGAAG. Lane M contains the molecular weight markers. Lanes 1 and 12 correspond to incubations in the absence of any acceptor but in the presence of ATP. Lanes 2, 7, 13 and 18 represent controls without ATP but with 200 ng of I or H pre-mRNAs. Bands in lanes 3-6 and 14-17 represent an average of 160 and 170%, respectively, of bands seen in lanes 8-11. Bands 19-22 are similar to those of 8-11.
###end p 56
###begin p 57
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 111 119 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trans</italic>
###xml 143 151 143 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 182 184 182 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 199 202 <span type="species:ncbi:10116">rat</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 328 333 <span type="species:ncbi:9606">human</span>
 Mutation of the downstream box of human COT exon 2 produces a gain of function in heterologous trans-splicing in vitro. Trans-splicing assays in vitro contained 0.9 ng (16 fmol) of 32P-radiolabeled rat A1 pre-mRNA (lanes 1-6) and increasing amounts, 10, 25 and 50 ng (111, 280 and 555 fmol), of human acceptor H (lanes 1-3) or human acceptor I (lanes 4-6).
###end p 57
###begin p 58
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 188 189 188 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 28 31 <span type="species:ncbi:10116">rat</span>
###xml 366 369 <span type="species:ncbi:10116">rat</span>
###xml 604 607 <span type="species:ncbi:10116">rat</span>
 Mutation on the ESE box of rat exon 2 from GAAGAAG to AAAAAAA inhibits trans-splicing in vivo. (A) Schematic representation of the COT minigenes E2E3COT (wt) and mutated E2E3COT-ESEmut. (B) Representative agarose gels of the RT-PCR amplification of DNA-free total RNA from HeLa cells transfected with E2E3COT and E2E3COT-ESEmut minigenes. cDNAs were amplified with rat COT primers COTE2.f (5'-GGACTCTCTTCCGCCCTTGC-3') and COTE2.r (5'-GGAATGTTCGTTCTTCAATTGAC-3') (left), and with COTE2.f and E3.r (5'-TGATGCAATGTCTTGCCAAC-3') (right). The set of primers COTE2.f and COTE2.r can only detect trans-spliced rat COT mRNAs. wt or Mut indicate the amplification cDNAs products of transfected HeLa cells with wild-type COT minigene E2E3COT or mutated COT minigene E2E3COT-ESE mut. M indicates the molecular DNA markers and H the products of amplified cDNAs from untransfected HeLa cells. The size of PCR products corresponds to the exonic representation.
###end p 58
###begin title 59
 Alignment of nucleotide sequences in exon 2 from the COT cDNA from various mammals
###end title 59
###begin p 60
###xml 53 56 <span type="species:ncbi:10116">rat</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 86 92 <span type="species:ncbi:9913">bovine</span>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
###xml 164 167 <span type="species:ncbi:9823">pig</span>
###xml 363 366 <span type="species:ncbi:10116">rat</span>
Sequences were obtained from the GenBank database of rat (U26033), human (H00195) and bovine (U65745). PCR amplified bands (shown in Fig. 1) from mouse (AF144397), pig (AF144398) and Cos7 monkey cultured cells (AF144399) were excised from the gel and sequenced. The numbers correspond to those of the GenBank database. All sequences end at the last nucleotide of rat COT exon 2. Purine-rich sequences in COT exon 2 are enclosed in squares. The alignments were performed using the Wisconsin Package Version 9.1 (Genetics Computer Group, Madison, WI).
###end p 60
###begin title 61
ACKNOWLEDGEMENTS
###end title 61
###begin p 62
The editorial help of Robin Rycroft is greatly acknowledged. This work was supported by Grant PB95-0012 from the Direccion General de Investigacion Cientifica y Tecnica, Grant 1999SGR0075 of the Generalitat de Catalunya (given to F.G.H.) and by a grant from Fundacion Ramon Areces (given to M.B.-E.). C.C. is the recipient of a fellowship from the Direccion General de Investigacion Cientifica y Tecnica, Spain.
###end p 62

